Platelet aggregation devices are specialized instruments used to measure the rate and extent to which platelets clump together, which is crucial for diagnosing and managing disorders related to blood clotting. These devices are used to assess the effectiveness of antiplatelet therapies, diagnose bleeding disorders, and evaluate platelet function in various clinical and research settings.
Sizing and Forecast
The platelet aggregation devices market size has grown exponentially in recent years. It will grow from $0.67 billion in 2023 to $0.83 billion in 2024 at a compound annual growth rate (CAGR) of 25.3%. The growth in the historic period can be attributed to increasing prevalence of cardiovascular diseases, rising incidences of bleeding disorders, growing awareness about health diagnostics, increase in surgical procedures, improved diagnostic accuracy.
The platelet aggregation devices market size is expected to see exponential growth in the next few years. It will grow to $2.07 billion in 2028 at a compound annual growth rate (CAGR) of 25.5%. The growth in the forecast period can be attributed to growing aging population, rising demand for point-of-care testing, expansion of personalized medicine, regulatory support and approvals, increasing prevalence of chronic diseases. Major trends in the forecast period include integration of artificial intelligence in diagnostics, development of portable platelet aggregation devices, increased collaboration between biotech firms and healthcare providers, rising importance of data analytics in healthcare, shift towards home-based diagnostics.
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/platelet-aggregation-devices-global-market-report
Segmentation & Regional Insights
The platelet aggregation devices market covered in this report is segmented –
1) By Product: Reagents, Systems, Consumables And Accessories
2) By Type: Four Channel, Dual Channel, Eight Channel
3) By Technology: Optical, Impedance, Other Technologies
4) By Application: Clinical Applications, Research Applications, Cardiovascular Applications, Orthopedic Applications, Other Applications
5) By End-User: Standalone Hospitals, Diagnostic Laboratories, Research And Academic Institutes, Other End Users
North America was the largest region in the platelet aggregation devices market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the platelet aggregation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15896&type=smp
Major Driver Impacting Market Growth
The increasing incidence of target diseases is expected to drive the platelet aggregation devices market going forward. Target diseases are specific medical conditions that are the focus of prevention, diagnosis, and treatment efforts due to their significant impact on public health, such as cancer, cardiovascular diseases, and diabetes. Platelet aggregation devices help in decreasing the incidence of target diseases by enabling early detection and effective management of thrombotic risks, thereby preventing complications like heart attacks and strokes in vulnerable populations. For instance, in February 2024, according to statistics published by the International Agency for Research on Cancer (IARC), a France-based specialized cancer agency of the World Health Organization (WHO), the world saw approximately 20 million new cancer cases and 9.7 million deaths in 2022, with projections indicating a 77% increase to over 35 million new cases by 2050; lung cancer was the most prevalent globally with 2.5 million new cases (12.4%), followed by female breast cancer (2.3 million cases, 11.6%), colorectal cancer (1.9 million cases, 9.6%), prostate cancer (1.5 million, 7.3%), and stomach cancer (970,000, 4.9%). Therefore, the increasing incidence of target diseases is driving the growth of the platelet aggregation devices market.
Key Industry Players
Major companies operating in the platelet aggregation devices market are Roche Holding AG, Cytiva (Danaher Corp.), Siemens Healthineers, Sysmex Corporation, WerfenLife S.A., Haemonetics Corporation, Helena Laboratories Corporation, Sarstedt AG & Co. KG, Sekisui Diagnostics LLC, Diagnostica Stago, Accriva Diagnostics Holdings Inc., Drucker Diagnostics, Sentinel CH. SpA, ADInstruments, Chrono-Log Corporation, Bio/Data Corporation, Haemochrom Diagnostica GmbH, AggreDyne Inc., Hart Biologicals Ltd., Stago
The platelet aggregation devices market report table of contents includes:
1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
